Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 1999

View Archived Issues

Company Profile: HIV-VAC

Cel-Sci focuses clinical efforts on Multikine development

GenSci to form subsidiary focused on treatment of bone diseases

Sangamo and Schering AG enter research agreement for Universal GeneTools technology

Structural Bioinformatics receives SBIR grant for asthma treatment

FDA approves new emergency contraceptive product

Amylin acquires patent rights for exendin-4 gene

MacroChem awarded U.S. patent for Topiglan

MacroChem files US patent application for antifungal nail lacquer

Lilly launches reusable growth hormone delivery device for Humatrope

Roche Canada obtains licensing and marketing rights to TNK-tPA

Lundbeck establishes various collaborative agreements just after close of first half

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Meiji Seika also shows interest in study of integrin receptor antagonists

NMI-377, an NO-donating diclofenac derivative with decreased GI side effects

Ferring's antidiuretic agent F-992 evaluated in healthy volunteers

British Biotech reports results of marimastat Study 145 in gastric cancer

Takeda and Lilly launch insulin sensitizer in first market, expand marketing relationship

Cytoskeleton employs novel HTS assay to identify new tubulin ligands

Berlin Chemie launches Sympal in Germany

Alcon suspends distribution of ophthalmic NSAIDs

Highlights from ACS: integrin antagonist SC-72115 is a potent angiogenesis inhibitor in vivo

P-SCN-Bz-HEHA, a bifunctional chelating agent designed to enable use of Ac-225 in radioimmunotherapy

German lab synthesizes new series of oxazolidinones

Bone resorption inhibitors, vitronectin receptor antagonists prepared at HMR

Celltech claims novel series of cell adhesion inhibitors

Chemokine receptor antagonists discovered through LeukoSite-Kyowa Hakko collaboration

Antiviral quinolinecarboxylic acid compounds reported by Sankyo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...